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Abstract BF is Beta-adreno receptor antagonist and used as an Anti-
Hypertensive Drug. BF gives the blocking action on β1-adrenergic receptors 
in the heart and vascular smooth muscle. The present review compiles the 
various approaches implemented for quantification of BF in bulk drug, 
pharmaceutical matrix and biological fluid. This review represents more 
than 50 analytical methods which include capillary electrophoresis, HPLC, 
HPTLC, UV-Spectroscopy, UPLC, impurity profiling and electrochemical 
methods implemented for estimation of BF as a single component as well as 
in multicomponent.
Keyword: BF; Bioanalytical; UPLC/LC-MS; capillary electrophoresis; impurity 
profile
1. INTRODUCTION
BF is an extremely discriminatory β1-adrenergic blocker [1]. BF is 
chemically: (RS)-1-[4-[[2-(1- Methylethoxy) ethoxy] methyl] phenoxy] 
-3-[(1 methyl ethyl) amino] propan-2-ol fumarate Figure 1. It is 
official in, USP. BF has similar structure to metoprolol, bopindolol, 
hydrochlorothiazide, atenolol [2]. Structure of BF, there is two substituents 
at para position of benzene provide the activity of β-selectivity, In which 
it has two substituents in para position of benzene which might be the 
activity of β- selectivity [3]. White crystalline powder of BF was soluble 
in water, methanol, ethanol, and chloroform. [4]. BF blocks catecholamine 








vascular smooth muscle, with decreasing the heart rate, cardiac output, 
systolic and diastolic blood pressure, and may be response orthostatic 
hypotension [5]. β-Blocker with calcium channel blocker mixture has 
efficacy in definite cardiovascular diseases like angina pectoris, myocardial 
infarction and hypertension [4]. For the decrease of workload on the 
heart and hence oxygen demands, so that the drug is pointed toward for 
secondary prevention of myocardial infarction, parallel therapy in patients 
with stable chronic heart failure, and for the treatment of hypertension and 
angina pectoris[5]. About 80% bioavailability given by BF after 10 mg oral 
dose[6]. The first pass metabolism of BF is about 20% and binding to serum 
proteins is approximately 30% [5]. The concentrations of plasma were 
taken in between 5 mg to 20 mg. It is contraindicated in person suffering 
from Psoriasis, Myasthenia Gravis, Sinus bradycardia, diabetes, depression 
and during Pregnancy. BF is available in combination with other drugs like 
HCT, AMD B, IRBE, CELI, METO T [7].
Figure 1: Chemical structure of BF.
2. ANALYTICAL ACCOUNTS ON BF
A variety of analytically urbanized methods like UV/Vis-Spectrophotometry, 
High-Performance Liquid Chromatography (HPLC), High-Performance 
Thin-Layer chromatography (HPTLC), Ultra Pressure Liquid 
Chromatography(UPLC), Liquid Chromatography-Mass Spectrometry (LC-
MS), Capillary Electrophoresis and Stability indicating methods have been 
studied for analysis of BF. The present papers described consolidate analytical 
methods published so far estimation of BF in bulk and pharmaceutical 
formulation as well as in biological samples. In literature reported method 
describe the analysis of BF in various dosage forms as single components as 
well as in combination with HCT, AMD B, IRBE, CELI, METO T, tropaeolin 
and Bromocresol green. Summary of these methods for determination of BF 
is shown in Figure 2.
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Figure 2: Analytical methods for BF.









BF is the official drug in the (USP29) united state of pharmacopeia (2004). 
USP reported HPLC assay method using 4.6 mm × 12.5 cm column that 
contain packing L7 as a stationary phase and a mobile phase consist mixture 
of (65:35 % v/v). Water-acetonitrile used as diluents to 1 L portion add 5 mL 
heptaflurobutyric acid, 5 mL diethyl amine and 2.5 mL formic acid with flow 
rate 1 mL/min, the column outflow was scan at 273 nm [8]. 
Table 1: Dosage form, route of administration and recommended dose of BF.







Adult Hypertension 5 mg/day and maxim. 
20 mg.
Tablet Patients with renal impairment: Not exceed 10 mg once daily.
Tablet
Patients with severe liver impairment: No 
dosage adjustment is required, however careful 
monitoring is advised.
Tablet
The maximum recommended dose is 10 mg 
once daily.
Elderly: No dosage adjustment is normally 
required. It is recommended to start with the 
lowest possible dose.
Children: There is no experience with 
bisoprolol in children, therefore its use cannot 
be recommended for children.
4. UV/VIS-SPECTROPHOTOMETRIC METHODS OF BF [9 -20]
In article about nine UV-Spectrophotometric methods have been fixed for 
assurance of BFsingle and in combination of different dosage form. Also one 
spectroflurometric method has been accounted for determination of BF. The 
detailed summary spectrophotometer and spectroflurometer designating the 
basic principle, sample matrix, linearity and retention time in Table 2.
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Table 2: Spectrophotometric methods used for determination of BF alone and 














1 BIS with 
bromocresol 
green
Zero order 402 7 - 80 0.9998 LOD- 1.78 
LOQ- 5.41 
9
2 BF and 
HCT
First order 223 & 274 BIS 8 - 96 
&





3 BF Zero order 412 5 - 30 0.9997 LOD- 0.67 
LOQ- 2.23 
11
4 BIS using 
methyl 
orange
Zero order 427 0.8 - 9 0.9997 LOD- 0.20 
LOQ- 0.66 
12
5 AMD B and 
BF









6 BF by using 
tropaeolin 
00
Zero order 412 5 - 30 0.9995 LOD- 0.67 
LOQ- 2.23 
14
7 BF Zero order 532 and 
626
100 - 500 
&





8 IRB and 
BHF













 LOQ- 4.17 
and 12.06
16
9 BF and 
HCT
First order BF 285.5 
&
HCT 264.5 
 1.2 - 59 0.9997
&
0.9998






10 BF with 
BPB and 
BCP





In BPB for 
BIS
0.9976




BPB and in 
BCP for BIS 
0.1791 and
0.5868, and
LOQ in BPB 
























11 BF and 
PRH





   0.9998
    and







12 BF and 
HCT










5. SPECTROFLUROMETRIC METHOD OF BF
Hashem et al. (2016) reported IRB and BHF through spectroflurometric 
method. It is depend  on charge transfer reaction between the designed 
drugs and 7-Chloro-4-nitrobenzen-2-oxa-1; 3-diazole NBD-CI. Dilution was 
prepared by using specific volume of NBD-CI (0.1%, w/v).By using 5 mL with 
acetonitrile it get heated and after cooling the fusion of solution was attenuate 
to 10 mL with acetonitrile and methanol for IRB and BHF, respectively. 
The absorbance was recorded at 476 and 479 for IRB and BHF, at colored 
concentration respectively against the reagent blank treated similarly. The 
linearity was obeyed in the range of 2.5–8 μg/mL for IRB and 6–16 μg/mL 
for BHF. This method also gives detection limits of 0.18 and 0.39μg/mL and 
a secondary quantification limit of 0.55 and 1.17μg/mL for IRB and BHF. 
The statistical evaluation of the results with the results of reported methods 
reflected that there was no major differentiation [16].
6. CHROMATOGRAPHIC SYNOPSIS 
6.1 High-Performance Liquid-Chromatography [21-42]
Distant from Pharmacopoeial methods many HPLC methods were accounted 
for assurance for BF in pharmaceutical formulation. The outlined of expressed 
HPLC methods specifically the mobile phase used for estimation, columns, 
wavelength, correlation coefficient and linearity range is shown in the Table 3.





Columns Mobile phase system Discussion Ref





0.1 M potassium 
dihydrogen phosphate 
buffer and acetonitrile 
in the ratio of (70:30 
% v/v)
Detection of BF and HCT 
was carried out at 228 nm and 
linearity obeyed in the range 
of 2.5–50 µg/mL and 6.25–
125μg/mL. Retention time 
for BF and HCT was found to 
be 5.058 min and 2.783 min.
21
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Detection of BF and HCT 
was carried out at 225nm. 
Linearity range for BF and 
HCT 0.50–12.00 and 0.20–
8.00 µg/mL Correlation 
coefficient for BF and HCT 
0.999 and 0.999. Retention 
time for BF and HCT  5.058 
min and 2.783 min.
22
3. BF and 
AMD
(tablet)
Luna C18-2 25 mM ammonium 
acetate adjusted to pH 
5.0 and methanol 
(65:35 % v/v)
Detection of BF and AMD 
was carried out at 230 nm. 
Linearity was established 
in the range of 8–33 µg/mL. 
Retention time was 1.45 min 
and 3.91 min for BF and 
AMD.
Correlation Coefficient for 




Hypersil ODS mixture of buffer and 
acetonitrile in the ratio 
of (700:300 % v/v )
Detection of BF was carried 
out at 208nm. Retention 
time of 3.146 min. Linearity 








buffer (pH 5.6) and 
acetonitrile in the ratio 
of (750:250 % v/v)
Detection of BIS F was 
carried out at 226nm. 
Linearity at 6 different levels 
from 25 µg/mL to 100 µg/mL. 
The retention time of BIS 













Detection of BIS F and AMD 
B was carried out at 267nm. 
Correlation Coefficient For 
BIS 0.998 and AMD besylate 
0.999.
26







KH2PO4 (40:60% v/v 
and pH 3.5)
Detection of BF and HCT 
was carried out at 232nm. 
Linearity: - 1-7 and 2.5-
17.5µg/mL for BF and HCT. 
Amplitudes at 228.4 and 
283nm of BF and HCT. 
Correlation Coefficient For 
BF 0.9999 and for HCT 
0.9999. Retention Time:- 
BF and HCT were eluted at 






















Detection of BF was carried 
out at excitation/emission 
275/305 nm. Linearity was 
found to be 5 - 250 ng/mL. 
Correlation coefficient of 
0.999.
28







(40:60 % v/v,  pH 3)
Detection of BF and HCT 
was carried out at 228. For 
both BF and HCT linearity 
was found to be 20-100 µg/
mL.The retention time of 
BF and HCT were 3.3 min 
and 6.25 min. correlation 
coefficient 0.998 and 0.999.
29
10. BF C18 column 
Kromasil 100-
5C18
Phosphate buffer (pH 
3.5) and acetonitrile 
(70:30 % v/v) 1ml/min
Detection of BF was carried 
out at 225 nm.  Linearity 
is 5-90µg/mL. Retention 
time 1.158 min.Correlation 







Water / methanol / 
acetonitrile in a ratio 
of (50:30:20 % v/v/v)
Detection of BF was carried 
out at 225nm. Two areas of 
linearity in the range of 0.8 
- 80 g/ mL and 80 - 1000 g/
ML.
Correlation coefficient 0.999 
and intercept 0.4953 with a 
regression coefficient R2 = 
0.999. LOD = 1.3 g/mL LOQ 
= 3.98 g/mL.
31











acid buffer solution 
(80:20% v/v)
Detection of BF and HCT 
was carried out at 220nm. 
Linearity 1.50–46.20and 
3.80–114.00 µg/mL. 
Correlation coefficient 0.9998 
and 0.9998. Recovery: 98–
102 % for active ingredients 
(B for HCT), 90–110 % for 
impurities (A, L, K For BF 
impurity).
32





Acetonitrile- 0.050 M 
ammonium phosphate 
buffer (4:6 % v/v).
Detection of BF and HCT 
was carried out at 226nm. 
Linearity: - 1 to 10 µg/mL.
Regression coefficient of the 
linearity test was 0.9996.
33
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14. BF with 
HCT
Zodiacsil-C18 buffer solution (pH 
3.60) containing 5 mM 
monobasic potassium 
phosphate in milliQ-
water. Mobile phase B 
consists of a mixture 
of acetonitrile and 
methanol in the ratio 
(80:20 % v/v)
Detection of BF and HCT 
was carried out at 226nm. 
Correlation coefficient 
obtained was 0.999. Stability 
indicating in the range of 
LOQ to 150%.The retention 








Chiralpak IB n-hexane/ethanol 
95/5 % v/v),  0.2% 
DEA)
Detection of BIS was carried 
out at 223nm. Correlation 
Coefficient was found to be 
0.8635.
Retention Time was over 100 
min.
35







phosphate buffer (pH 
3.0, adjusted with 
orthophosphoric acid; 
20 mM) (50:50% v/v)
Detection of BF was 
carried out at 222nm. 
Linearity in the range of 
10–100 µg/mL.Correlation 
Coefficient:-0.999.
LOD and LOQ values were 









 (77.5: 22.5 % v/v)
Detection of BF was carried 
out at excitation/emission 
232/320 nm. Linearity range 
is 3 to 200 ng/mL, correlation 
coefficient of 0.9998 The 
LOQ was 3 ng/mL. Retention 
Time was detected 4.5min 
and 7.24 min.
37
18. BF Zorbax SB-
C18 Solvent 
Saver Plus
0.1% formic acid 
solution – acetonitrile 
(50-50 % v/v)
Detection of BF was carried 
out at 226 nm. Linearity in the 
range of 1 ng/Ml and 100 ng/
mL. Correlation Coefficient 
of 0.998599,
LOQ is 1 ng/mL. Retention 







Detection of BF was carried 
out at exci. /emmi 275/305 
nm. Linearity in the range of 
10–100 ng/mL. Correlation 
Coefficient: -  0.994. LOD: 3 













Columns Mobile phase system Discussion Ref





water and formic acid 
as solvent A in the 
ratio ( 99% : 1% (v/v) 
and acetonitrile and 
formic acid as solvent 
B in the ratio (99% : 
1% v/v)
Detection of BF was carried 
out at 225nm. The retention 
times are 16.2 min.
40








Detection of BF and HCT 
was carried out at 259nm. 
Linearity range of 40-120 μg/
mL (BF) and 50-150 μg/mL 
(HCT).
Correlation Coefficient :- 
0.9999
LOQ was 0.398 and 0.385 μg/
mL for BIS and HCT. LOD 
(μg/ml) 0.398 and 0.385.
41
22. BF and 
HCT
Zodiac C18 phosphate buffer and 
acetonitrile in the ratio 
of (80:20 % v/v)
Detection of BF and HCT 
was carried out at 208nm. 
Linearity was obeyed in 
the range 2.5-75μg/ml and 
3-90μg/ml of BF and HCT.
The retention time of BF and 
HCT was found to be 2.253 
min and 4.425 min. LOD and 
LOQ for BF 2μg/ml and 6μg/
ml and for HCT 0.9 μg/ml 
and 1.8 μg/mL.
42
6.2 High- Performance -Thin- Layer Chromatography [43-45]
About 3 HPTLC methods have been studied for simulation determination of 
BF with HCT and camphorsulphonic acid in different pharmaceutical dosage 
form.
Emanual M Patelia et al. (2013) investigated specific and precise method 
for quantitative estimation of BFand HCT in pharmaceutical dosage form. The 
separation of the BF and HCT was conceded on aluminum plate precoated with 
silica gel 60F254using mobile phase chloroform: ethanol: glacial acetic acid 
(5:1.5:0.2 v/v/v).The Rf value was found to be 0.62 and 0.40 for BF and HCT, 
respectively when the densitometry quantification was performed maximum at 
225 nm. For analysis of BF and HCT, linearity was studied in the range of 200 - 
1200 ng/band and 100 - 800 ng/band, respectively. Accurateness of the method 
was studied by % recovery and found to be 100.02 ± 1.14% for BF and 99.91 ± 
0.96% for HCT [43]. Similarly; Rao et al. (2013) also developed and validated an 
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effortlessmanner for determination of BF and HCT. The separation was achieved 
on aluminum plates percolated silica gel 60 F254 using mixture of ethyl acetate: 
methanol: ammonia 10:0.5:0.5 v/v/v) as mobile phase with Rf of BF and HCT 
were 0.60 and 0.38, in that order and detection was monitored at 225 nm. For 
estimation of drugs, the linearity experiment was performed in the range of 150-
900 ng/spot for BF and 100-600 ng/spot for HCT. Linear regression for BF and 
HCT was 0.999 [44]. The established methods were validated for correctness, 
robustness and specificity as per ICH guidelines.
Patel et al. (2011) reported an enantiomer separation of BF by TLC and 
HPTLC by means of (+)-10-camphorsulphonic acid as a chiral selector. 
Chromatographic separation of BF was performed with optically pure 
(+)-10-camphorsulphonic acid as a chiral selector. The mobile phase set for 
separation was triethyl amine–methanol–1-pentanol (0.14:9.9:0.18, %v/v/v). 
For TLC detection was executed at UV-chamber at short wavelength 254 nm 
and for HPTLC densitometry detection performed at 224 nm. The calibration 
ranges for both the isomers were 5-30 μg/mL [45].
7.  STABILITY- INDICATING METHODS (SIM) FOR ESTIMATION 
OF BF [46-51]
With reference four stability indicating methods studied accordingly for 
persistence of BF in bulk substance and pharmaceutical dosage form 
implementing several analytical techniques. The reported stability indicating 
methods for BF illustrating dosage form, column, mobile phase and linearity 
and retention factor presented in [Table: 4].
Table 4: Stability indicating methods of BF by HPLC and UPLC.
Sr. 
No
Drugs Formulation Column Mobile Phase 
System
Detection Discussion Ref




(75:25% v/v, pH 
5.6)
226 nm Linearity was found to 







































259 nm Linearity for both BF 
and HCT: - 40-120 
and 50-150 μg/mL 
.Correlation Coefficient 
was found to be 0.9999. 
Retention Times 3.688 
min and 5.824 min.
48
4 BF Tablet HP1200 A c e t o n i t r i l e -
water solution (10 
mM ammonium-
acetate, pH 4.0, 
adjusted with 
c o n c e n t r a t e d 
acetic acid) at a 
ratio of ( 92:8 % 
v/v )
230 nm R-value for zero-order 








Mobile phase A 









B consists of 
a mixture of 
acetonitrile and 
methanol in the 
ratio 80:20 % v/v)
226 nm Correlation Coefficient 
was found to be 0.999.
A retention time was 











(50:50 % v/v) 
225 nm Linearity in the range of 
0.5– 250 μg /mL for BF 
and 0.5–150μg/mL.
Correlation Coefficient 
(r) was found to be 
0.999. For human urine 
linear in the range 
between 0.5 and 10 μg /
mL for HCT and 0.5–30 
μg/ mL for BF. LOD and 
LOQ 0.07– 0.21 μg/ mL 
; and 0.01–0.03 μg/ mL 
for BF and HCT
51
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8. CAPILLARY ZONE ELECTROPHORESIS METHOD [52-55]
Laszlo Gagyi et al. (2006) established a effortless capillary electrophoresis 
method for estimation of various stereoselective β1-blockers and H1- 
antihistamines by human serum transferrin. For the chiral separation of 
stereoselective β1-blockers and H1- antihistamines, pseudostationary protein 
zone was used. In that developed method about 15 compounds were screened 
and nearly all of them illustrate longer migration time, showed a communication 
with transferrin. Stereoselective interaction was observed only for five β1-
blockers(CEL, TALINO, MEPIN, BOPIN, and OXPRE) and for one H1-
antihistamine (bromopheniramine). A polyacrylamide-coated (3%, noncross-
linked)capillary (34 cm effective length 650 mm id) was carried out[52].
Hong-Bing Duanetal. (2015) described a new routine estimation of METO 
TandBF. In that developed method, capillary electrophoresis fixed with tris 
(2, 2’-bipyridyl)-ruthenium (II) electrochemiluminescence for the estimationas 
well asillustrates relationship between the METO T and BF and human serum 
albumin. There are different parameters were selected for optimization of CZE 
separation; because they affect the CZE separation and ECL detection, the 
optimized parameters like pH, amount of running buffer, detachment voltage 
and potential exposures. Under enhanced condition METO T and BF were 
well separated and identified within 10 min [53].
Jingwu Wang et al. (2008) illustrate daspeedy, selective, and responsive 
capillary zone electrophoresis (CZE) attached through tris (2,2-bipyridyl) 
ruthenium(II)-based end-column electrogenerated chemiluminescence (ECL)
was utilized to estimate BF in bulk and tablets subsequent to its separation 
from METO. Tetrahydrofuran were used as an additive in the running buffer 
to receive the absolute ECL peak of BF. It react with tris (2, 2-bipyridyl) 
ruthenium (II) ECL system. Under the advanced experimental situation, BF 
was separated successfully and efficiently from METO and other co-existed 
materials in tablets and urine samples [54].
Laszlo Gagyiet al. (2008) reported the stereoselective detection of 
β-blockers by cyclodextrins within capillary zone electrophoresis. This category 
of medicinal agent was resolved by cardiovascular system disease and its 
derivativechiral aryloxy-propanolamine. In general, the S (−) enantiomer aremore 
active than the R (+) enantiomer. Study understand the appliance of a choice of 
cyclodextrin derivatives, hydroxypropyl-β-cyclodextrins, at randommethylated 
β-cyclodextrin, sulphated β-cyclodextrin and sulphated α-cyclodextrins for the 
stereoselective examination of β-blockers. Separation was obtained for BOPI, 
CARV, MEPI, PIND and ALPR, while only partial separation was observed for 








9.  ACCOUNT ON BIO-ANALYTICAL METHOD FOR 
DETERMINATION OF BF [56-67]
Bioanalytical methods are used for the quantitation of drugs and their 
metabolites and biological molecule in unnatural location or concentration) 
and biotic (macromolecule, large molecule drugs and metabolites) in organic 
systems[56]. Literature survey revealed that LC-MS/MS and HPLC and 
are predominantly used for the bioanalysis of BF. In Bioanalytical method 
validation sample is extracted from plasma with help of extraction techniques 
such as protein precipitation, liquid-liquid extraction and solid phase extraction 
techniques. In most of methods methanol was used as solvent for extraction 
of BF in biological fluids. Bioanalytical methods for determination of BF are 
summarized in [Table: 5].








1 BF Human 
plasma
RP-C18 column 




Sevgi Tatar Uluet al. Described 
derivatization of BF with 4-chloro- 
7-nitro-2, 1, 3-benzoxadiazole in borate 
buffer at pH 9.5 to yield a fluorescent 
product. Plasma samples (BF and IS) 
were extracted employing a liquid–liquid 
extraction method. Ephedrine was used 
as internal standard. Linearity obeyed in 
the range of 10 –2,000 ng/mL Retention 
times was approximately 4.79 min for BF 
and 3.46 min for IS.
57
2 AMD and 
BF 
Rat plasma Diamonsil C18 
column (50 mm × 4.6 
mm, 5 μm),
 Methanol: water: 
formic acid 
(75:25:0.01, % v/v/v)
HuichaoChanget al. Illustrated a sensitive, 
specific liquid chromatography–tandem 
mass spectrometry method for quantitative 
determination of AMD and BF. The 
analytes and IS were isolated plasma 
samples by liquid–liquid extraction. 
Linearity was followed in the range of 
0.2–50 ng/mL and correlation coefficient 
0.9961 for both BF and AMD. Retention 
time 2.12, 1.96 and 1.89 min for both.
58
3 BF Human 
plasma
RP-C18 Column ( 3 × 
100 mm, 3.5 μm),
0.1% formic acid 
solution – acetonitrile 
(50-50 % v/v)
Gabriela Peste et al. Developed specific 
liquid chromatography–tandem mass 
spectrometrymethoddetermination of BF . 
The analytes extracted using liquid-liquid 
extraction method and metoprolol was IS. 
Linearity obeyed in the range of 1 ng/mL 
and 100 ng/mL. Correlation Coefficient of 
600.99. Retention time, 1.7 min and 1.9 
min. result given by BF and METO.
59
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4 BF Human 
plasma
Kromasil C18 column
 (150 × 4.6 mm,5 
μm), Methanol and 
0.05% phosphoric 
acid (40:60 % v/v )
Ming Zhang et al. developed A three-phase 
solvent bar microextraction technique 
combined with high performance liquid 
chromatography fluorescence detection 
was for quantitative determination of 
BF. METO was used as the IS. Linearity 
obeyed in the range of 10–100 µg/mL 






Kromasil C18 column 
(150 x 4.6 mm,5 μm)
phosphate buffer 
0.1 M adjusted to 
pH 3.4 ± 0.1 with 
hydrochloric acid
E. Caudron et al. described method 
for the simultaneous determination 
of cardiovascular drugs. Solid-phase 
extraction technique was used for 
determination of BF. PROP was used as 
the IS.
Linearity 10–500 ng/ml for CEL is 5–250 
ng/ml for BF and 20–1000 ng/mL for 
IRB.
Retention time:-BF: 7.31 CEL: 5.19 IRB: 
16.32
Linear Regression Coefficient (r):-CEL 
0.9996, BF 0.9990,  IRB 0.9994
61
6 BF Human 
plasma
Chromolith RP-




 pH 3.5 acetonitrile 
(77.5:22.5% v/v/v ) 
CorneliuOniscu et al. illuminate 
liquid- liquid extraction with diethyl 
ether, at alkaline pH, followed by back-
extraction with phosphoric acid, and 
liquid chromatography analysis with 
fluorescence detection for BF. METO 
used as IS in this study.
Linearity obeys in the range of 3 ng/
mL and 200 ng/mL. Retention time was 
4.5min and 7.24 min.
Correlation coefficient was found 0.99981.
62




RP- C18 Nucleosil 
column acetonitrile–
HPLC water with 
1.2% (w/v) of 
triethylamine and the 
pH adjusted to 3 with 
85%orthophosphoric 
acid 
(18:82, 20:80, % v/v)
A. J. Brazaet al. wasdevelopedtwo 
different liquid–liquid extractions 
method. Fluorometric detection used for 
the identification of BF and METOP.
Linearity was in the range of 6.25–200 
ng/mL for both BF and METO.
Retention times for BF and METO were 
8.7 and 3.2 min.
 R 2 = 0.9857 and
 R 2 = 0.9959.
63




C18 Nucleosil column 
(5-mm 12.5 cm_4 
mm ), acetonitrile and 
67 mM Sorensen’s 
phosphate buffer (pH 
5.0) (30/70 % v/v ) 
P. Modamio et al. Illustrated a 
predetermined procedure i.e. RP-HPLC 
with UV detection which is used for 
identification of CEL and BF. Phosphate 
buffer used as a standard solution. 

















9 BF  Human 
plasma
Zorbax SB-C18 
(100 mm x 3.0 mm ) 
mixture of methanol  
and (0.1% (v/v) acetic 
acid 
(40:60 % v/v ) in 
water at 
48 ºC
Exp Clin Cardiol et al. was developed 
multiple reaction monitoring (MRM) 
mode using an ion trap mass spectrometer 
equipped with an electro spray ion source 
for monitoring the BF Methanol was used 
as an internal standard.LOQ was found 
for BF 1.78 – 85.44ng/mL. Correlation 
coefficient greater than 0.993. Retention 
Time of BF in six different lots of blank 













Luna C18 (150 mm 




acid and 10 mM 
ammonium formate at 
pH 4.1
Oskar Gonzalez et al. reported 
simultaneous analysis of several drugs 
usually combined in cardiovascular 
therapy. Plasma samples were extracted 
employing a simple protein precipitation 
extraction with acetonitrile and 
pravastatin was used as IS.
66
11 BF Plasma 
serum
stainless steel tube 
(125 x 5 mm
ID) 1 mM 
camphorsulphonic
acid in methanol
R. J. Eastwood et al.reported measurement 
of bisoprolol in plasma by using high 
performance liquid chromatography. Tris 
solution, benzimidazole which is aqueous 
internal standard and methyl t-butyl 
ether mixed with the sample vortex for 
30 seconds. After the centrifugation at 
particular portion resulting extract is 
analyzed on a micro particulate silica 
column using 1 mM camphorsulphonic 
acid in methanol as the mobile phase. At 
215 nm detection of limit and detection of 
quantitation can be calculated. Minimal 
interference from either commonly 
prescribed drugs or endogenous 
compounds can be determined.
67
10. IMPURITY PROFILING ON BF [68-72]
The impurity profiling is designed with objectives to establish specific link 
between two or more samples, ascending drug distribution pattern, for 
identification of sources of drug samples and also for monitoring the process 
for drug manufacturing [68]. According to the ICH guidelines impurities are 
matter in the product which is not active pharmaceutical ingredients or the 
excepient used to manufacture it [69].An impurity profile has been established 
for quantification of BF alone and in combined dosage form. There are a various 
types of impurities present in BF. Following explanation can be established the 
impurity present in BF and their combined dosage form.
An Insight on 
Analytical Profile 
on Bisoprolol 

































































































































































































































































































































































































































































































































































An Insight on 
Analytical Profile 
on Bisoprolol 














































































































































































































































An Insight on 
Analytical Profile 
on Bisoprolol 




















































Tijana Rakic et al. (2014) established hydrophilic inter face liquid 
chromatographic method for study of BF and its impurities A and C. The 
chemometric strategy was resolved to systems activities and establishing the 
mathematical association between acetonitrile content which was present in 
mobile phase, pH of the water phase and buffer concentration in the water 
phase and chromatographic responses. Investigation all studies of BF from 
beginning to end Chromatographic technique and its impurities was established 
on HILIC 100Å (100 mm x 4.5 mm, 2.6 µm particle size); using mobile phase 
mixture consist was acetonitrile – water phase (35 mM ammonium acetate, pH 
4.9 manage with glacial acetic acid) (85:15 v/v) with flow rate 1 mL/min and 
analysis was performed at ambient temperature. Impurities of BF (impurity A 
and impurity C) are shown in Table 6 [70].
Ivana Mitrevska et al. (2017) established identification, structural 
interpretation and qualification of a degradation impurity RRT 0.95 of BF in 
film-coated tablets. The impurity of relative retention time gives at 0.95 was 
observed in the stress thermal degradation study of the BF film-coated tablets 
with identification, characterization and quantitation was performed using 
HPLC/DAD/ESI-MS method. The configuration of the embattled Impurity 
RRT 0.95 was shown in Table 6 with molecular mass of BF were 406 [71].
Venkata Narasimha Rao Ganipisetty et al. (2016) studied twelve impurities 
of BF and HCT and separated simultaneously using HPLC technique. Out 
of 12 reported impurities, five were found to be potential degradants. During 
the validation of stability indicating method, the focus was on the critical 
parameters in resolving the degradants from the main components. These 
parameters include Hand, temperature solvents because BF and HCT have 
different solubilities and polarities. The method was precise (RSD<1.0%), 
accurate, linear (r2>0.999), robust, and stability indicating in the range of 
LOQ to 150% [72].
11. ELECTROCHEMICAL METHODS:
11.1 Voltammetric methods for BF: [73-75]
Rajendra N. Goyal et al.(2011) recognized an voltammetric performance 
of BF by using graphite electrodes were completed with single wall carbon 
nanotubes. In comparison to BPPGE, EPPGE gives supplementary sharp 
peaks in oxidation of BF. In the variety 10 – 1000 mV/s in phosphate buffer 
solution of pH 7.2, the examination rate of repeated voltammogram was 
assorted. The limits of detection were found to be 2.8 × 10–7 M and 7.3 × 10–7 
M [73].Bozal et al (2012) wasreported Simultaneous estimation of BF and 
HCT in their pharmaceutical formulation by applying different voltammetric, 
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chromatographic, and spectrophotometric analytical methods. The level of 
difference pulse and square wave voltammetry techniques were used for the 
analysis of BF and HCT concurrently by measuring at with reference to 1400 
and 1100 mv. By using different electrolytes including H2SO4, phosphate, 
acetate, and BR buffers with different pH values between 0.3 and 12.0 
containing a constant amount of 20% methanol the voltammetric oxidation of 
BF and HCT were reported. BF was oxidized between pH 0.3 and 10.
Rajendra N. Goyal et al. (2007)studied a BF in pharmaceutical dosage 
form and urine using single-wall carbon nano tubes customized glassy carbon 
electrode. The SWNTs-modified GCE exhibited a sharp anodic peak at a 
potential of 950mV for the oxidation of BF. In good condition linearity was 
found in the range of 0.01–0.1mM in 0.5M phosphate buffer solution having 
pH 7.2 with a correlation coefficient of 0.9789 and limit of detection was 
reported at 8.27 × 10−7 M.
11.2 Potentiometric method for BF: [76-77]
Grzegorzbazylak et al. (2002) reported execution of analytical and 
biopharmaceutical screening data for beta-adrenergic-drug simple menting 
many macro cycle in HPLC Systems. In the cation-exchange HPLC technique 
for the studies applying acetonitrile – 40 mM phosphoric acid (15: 85,% v/v,) 
as a mobile phase. By employing crossbreed polymer silica packets in RP- 
HPLC it can be considered that promising surrogate in high throughput drug 
control process for examination of beta adrenergic agonist in humans and 
animals recommend the Potentiometric recognition [76].
Saad S.M. Hassan et al. (2003) reported the used of polymeric medium 
membrane sensors for purpose of β-blockers. This sensor was depending on 
the cations with tungs to phosphate anion as electro active materials. In some 
dosage form sensors are implemented for direct potentiometry of β-blockers.
for the construction of the sensor plastic membrane can be made by preparing 
composition 2:34:64% (w/ w) ion pair complex, PVC and DOP plasticizer. 
The sensor was uncomplicated for the purpose of b-blockers at a concentration 
level as low as 10-7 mol l-1 with an accuracy of 99.1 ±/1.3 %. [77].
12. CONCLUSION
The present review gives various analytical methods for the estimation of 
BF. A different analysis had perform which include, Bio-analytical, HPLC, 
HPTLC, UV/Vis-Spectroscopy, Spectroflurometry, capillary electrophoresis, 
stability indicating method, impurity profile and electrochemical method like 








its combined pharmaceutical formulations and in plasma. Through HPLC with 
UV detection has been found to be most studied for estimation of BF in bulk as 
well as pharmaceutical dosage forms, while hyphenated LS-MS, Bioanalytical, 
UPLC methods are reported for quantification of BF and its metabolite in 
plasma and other biological fluids. HPTLC and Stability-indicating by HPLC 
and HPTLC are also reported in literature survey. Certain Spectrophometric 
methods in UV-Visible along with spectroflurometric are most often used for 
assessment for BF. Various types of stability indicating method and impurity 
profiling method have been estimated.
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